Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 26 | 2025 | 2586 | 2.040 |
Why?
|
| Sexual Behavior | 4 | 2020 | 638 | 1.150 |
Why?
|
| Haiti | 14 | 2025 | 86 | 0.990 |
Why?
|
| Risk-Taking | 8 | 2025 | 457 | 0.900 |
Why?
|
| Emigrants and Immigrants | 2 | 2016 | 158 | 0.830 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 65 | 0.720 |
Why?
|
| Substance-Related Disorders | 6 | 2016 | 830 | 0.690 |
Why?
|
| Anti-HIV Agents | 5 | 2025 | 486 | 0.600 |
Why?
|
| Heart Failure | 1 | 2023 | 302 | 0.590 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2016 | 26 | 0.470 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 609 | 0.450 |
Why?
|
| Condoms | 1 | 2016 | 150 | 0.440 |
Why?
|
| Florida | 9 | 2025 | 478 | 0.440 |
Why?
|
| Adult | 24 | 2025 | 13872 | 0.400 |
Why?
|
| Female | 24 | 2025 | 24698 | 0.370 |
Why?
|
| Adolescent Behavior | 4 | 2025 | 281 | 0.370 |
Why?
|
| Humans | 34 | 2025 | 43102 | 0.360 |
Why?
|
| Adolescent | 10 | 2025 | 6081 | 0.340 |
Why?
|
| Risk Factors | 7 | 2020 | 3994 | 0.320 |
Why?
|
| Young Adult | 9 | 2025 | 5080 | 0.290 |
Why?
|
| Depression | 1 | 2016 | 863 | 0.280 |
Why?
|
| Stress, Psychological | 4 | 2025 | 661 | 0.280 |
Why?
|
| United States | 6 | 2025 | 5205 | 0.270 |
Why?
|
| HIV Seropositivity | 1 | 2009 | 196 | 0.270 |
Why?
|
| Health Education | 3 | 2005 | 363 | 0.260 |
Why?
|
| Pregnancy | 3 | 2023 | 1772 | 0.260 |
Why?
|
| Alcoholism | 3 | 2015 | 305 | 0.260 |
Why?
|
| Qualitative Research | 3 | 2025 | 574 | 0.250 |
Why?
|
| Cultural Competency | 2 | 2004 | 138 | 0.250 |
Why?
|
| Urban Health | 1 | 2007 | 101 | 0.250 |
Why?
|
| Sex Offenses | 1 | 2007 | 45 | 0.250 |
Why?
|
| Medication Adherence | 2 | 2025 | 182 | 0.230 |
Why?
|
| Teaching Materials | 1 | 2005 | 10 | 0.230 |
Why?
|
| Translating | 1 | 2005 | 18 | 0.230 |
Why?
|
| Behavioral Research | 1 | 2005 | 41 | 0.220 |
Why?
|
| Object Attachment | 1 | 2025 | 28 | 0.220 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2009 | 989 | 0.220 |
Why?
|
| Health Services Research | 1 | 2005 | 161 | 0.210 |
Why?
|
| Male | 18 | 2025 | 23409 | 0.210 |
Why?
|
| Psychometrics | 2 | 2025 | 358 | 0.210 |
Why?
|
| Sick Role | 1 | 2004 | 9 | 0.210 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2015 | 83 | 0.210 |
Why?
|
| Community Health Services | 1 | 2025 | 206 | 0.210 |
Why?
|
| Parent-Child Relations | 1 | 2025 | 127 | 0.200 |
Why?
|
| Cultural Characteristics | 1 | 2004 | 128 | 0.200 |
Why?
|
| Logistic Models | 2 | 2016 | 1009 | 0.200 |
Why?
|
| Tuberculosis | 1 | 2023 | 78 | 0.190 |
Why?
|
| Mental Health | 3 | 2025 | 385 | 0.170 |
Why?
|
| Middle Aged | 10 | 2025 | 12222 | 0.160 |
Why?
|
| Transients and Migrants | 1 | 2020 | 42 | 0.160 |
Why?
|
| Homosexuality, Male | 1 | 2025 | 486 | 0.150 |
Why?
|
| Minority Groups | 2 | 2004 | 690 | 0.150 |
Why?
|
| Health Status Disparities | 2 | 2004 | 719 | 0.150 |
Why?
|
| Anti-Retroviral Agents | 2 | 2021 | 160 | 0.150 |
Why?
|
| Interpersonal Relations | 1 | 2020 | 222 | 0.140 |
Why?
|
| Child | 3 | 2025 | 3443 | 0.140 |
Why?
|
| Social Support | 2 | 2025 | 445 | 0.140 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2018 | 11 | 0.140 |
Why?
|
| Alcohols | 1 | 2018 | 14 | 0.140 |
Why?
|
| Hypertension | 1 | 2025 | 835 | 0.140 |
Why?
|
| Residence Characteristics | 2 | 2017 | 363 | 0.120 |
Why?
|
| Health Services Accessibility | 4 | 2025 | 706 | 0.120 |
Why?
|
| Sex Factors | 2 | 2017 | 1028 | 0.120 |
Why?
|
| Negotiating | 1 | 2016 | 27 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2015 | 16 | 0.120 |
Why?
|
| Family Relations | 1 | 2016 | 46 | 0.120 |
Why?
|
| Safe Sex | 1 | 2016 | 78 | 0.120 |
Why?
|
| Triage | 1 | 2015 | 34 | 0.110 |
Why?
|
| Mass Screening | 2 | 2017 | 541 | 0.110 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2015 | 15 | 0.110 |
Why?
|
| Postpartum Period | 1 | 2016 | 92 | 0.110 |
Why?
|
| Perception | 1 | 2016 | 215 | 0.110 |
Why?
|
| Primary Prevention | 2 | 2005 | 63 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 749 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2015 | 243 | 0.100 |
Why?
|
| Patient Dropouts | 1 | 2013 | 32 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2007 | 760 | 0.100 |
Why?
|
| Focus Groups | 2 | 2025 | 423 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1070 | 0.090 |
Why?
|
| Educational Status | 3 | 2017 | 339 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 1234 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 154 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2013 | 229 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2025 | 1081 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2025 | 1759 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 3156 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2017 | 201 | 0.080 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2008 | 44 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 863 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2013 | 233 | 0.070 |
Why?
|
| Multilingualism | 2 | 2004 | 52 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 25 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2007 | 74 | 0.060 |
Why?
|
| Psychological Tests | 1 | 2007 | 56 | 0.060 |
Why?
|
| Urban Population | 2 | 2025 | 374 | 0.060 |
Why?
|
| Schools, Public Health | 1 | 2005 | 8 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2025 | 162 | 0.060 |
Why?
|
| Healthcare Disparities | 3 | 2004 | 590 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 118 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2007 | 141 | 0.060 |
Why?
|
| Adolescent Health Services | 1 | 2004 | 29 | 0.050 |
Why?
|
| Counseling | 1 | 2025 | 138 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2015 | 201 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2025 | 120 | 0.050 |
Why?
|
| Preventive Health Services | 1 | 2004 | 66 | 0.050 |
Why?
|
| Program Development | 1 | 2005 | 240 | 0.050 |
Why?
|
| Developing Countries | 1 | 2004 | 113 | 0.050 |
Why?
|
| Culture | 1 | 2005 | 172 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 638 | 0.050 |
Why?
|
| Viral Load | 1 | 2025 | 348 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2025 | 215 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2004 | 120 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2007 | 863 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 55 | 0.050 |
Why?
|
| Peer Group | 1 | 2025 | 177 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2004 | 178 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2025 | 452 | 0.050 |
Why?
|
| Schools | 1 | 2025 | 283 | 0.050 |
Why?
|
| Research Design | 1 | 2004 | 385 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2004 | 420 | 0.040 |
Why?
|
| Poverty | 1 | 2004 | 400 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 266 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2025 | 1600 | 0.040 |
Why?
|
| Motivation | 1 | 2025 | 513 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2003 | 226 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 734 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 497 | 0.040 |
Why?
|
| Dental Care | 1 | 2020 | 41 | 0.040 |
Why?
|
| Health Behavior | 1 | 2004 | 575 | 0.040 |
Why?
|
| Health Promotion | 1 | 2004 | 704 | 0.040 |
Why?
|
| Glutathione Synthase | 1 | 2018 | 1 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2018 | 3 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2018 | 35 | 0.030 |
Why?
|
| Blood Donors | 1 | 2018 | 20 | 0.030 |
Why?
|
| Quality of Life | 1 | 2003 | 616 | 0.030 |
Why?
|
| World Health Organization | 1 | 2017 | 36 | 0.030 |
Why?
|
| Membrane Microdomains | 1 | 2018 | 53 | 0.030 |
Why?
|
| HIV | 1 | 2018 | 100 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 107 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2018 | 112 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 158 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 457 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 518 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 667 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 532 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 8214 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2008 | 174 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1857 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 526 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1063 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2018 | 1003 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1285 | 0.020 |
Why?
|
| Syphilis | 1 | 2008 | 24 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 207 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 287 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2008 | 282 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 737 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 719 | 0.010 |
Why?
|
| Saint Lucia | 1 | 2004 | 3 | 0.010 |
Why?
|
| Trinidad and Tobago | 1 | 2004 | 4 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2004 | 152 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2004 | 138 | 0.010 |
Why?
|
| Relaxation Therapy | 1 | 2003 | 3 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2004 | 359 | 0.010 |
Why?
|
| Health Surveys | 1 | 2004 | 405 | 0.010 |
Why?
|
| Fatigue | 1 | 2003 | 100 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2004 | 338 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2003 | 180 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2004 | 380 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 235 | 0.010 |
Why?
|
| Parents | 1 | 2004 | 370 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2004 | 392 | 0.010 |
Why?
|
| Health Status | 1 | 2003 | 442 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 1604 | 0.010 |
Why?
|